TAO, NCT01076764 / 2009-016568-36: Effect of Otamixaban Versus Unfractionated Heparin + Eptifibatide in Patients With Unstable Angina/Non ST Elevation Myocardial Infarction Undergoing Early Invasive Strategy |
|
|
| Completed | 3 | 13220 | Europe, Canada, US, RoW | Otamixaban, XRP0673, Placebo (for Otamixaban), UFH, Unfractionated Heparin, Placebo (for UFH), Eptifibatide, Placebo (for Eptifibatide) | Sanofi | Acute Coronary Syndrome | 05/13 | 05/13 | | |